Single Use Bioreactor: The Ultimate Guide to Modern Bioprocessing
In recent years, the bioprocessing landscape has shifted decisively towards disposable technologies. The Single Use Bioreactor, long familiar to some laboratories and now increasingly standard in full-scale production, combines the convenience of disposables with the precision and control demanded by modern biotechnology. This comprehensive guide explores what a Single Use Bioreactor is, why it matters, how it works, and how organisations can evaluate, implement, and optimise these systems to support robust, compliant and cost‑effective biomanufacturing.
What is a Single Use Bioreactor?
Definition and context for Single Use Bioreactor systems
A Single Use Bioreactor (SUB) is a fermentation or cell culture vessel that relies on disposable, pre-sterilised bags or liners and integrated ancillary components to enable sterile processing without the need for traditional clean-in-place (CIP) and sterilisation-in-place (SIP) regimes for the primary vessel. In practice, a SUB includes a bioreactor bag or chamber, sometimes with an integrated sensor array, mixing mechanism, and connections to gas and fluid handling systems. The key idea is to provide a fully sealed, sterile environment that can be replaced or disposed of with minimal cleaning reverberations between runs.
Historically, bioreactors were primarily made from stainless steel and required extensive CIP/SIP cycles. The shift to single-use plastics and modular assemblies reduces water, energy and chemical use, shortens setup times, and lowers the risk of cross‑contamination. Crucially, the Single Use Bioreactor supports rapid changeovers between products, processes, or production scales while maintaining sterile barriers and process control.
Why the Single Use Bioreactor has become a cornerstone of modern bioprocessing
The rise of the Single Use Bioreactor is driven by several interlocking factors: speed, flexibility, capital efficiency, and regulatory alignment. In start‑ups and established biopharma alike, SUB platforms enable faster process development and scale‑up. They also streamline manufacturing by enabling parallel development workstreams, reducing facility downtime while new campaigns are commissioned. The net effect is a more agile manufacturing ecosystem that can respond quickly to changing demand and novel therapies.
Key benefits of a Single Use Bioreactor
Operational flexibility and faster changeovers
One of the most tangible advantages of the Single Use Bioreactor is the speed with which a new campaign can be introduced. A disposable bag and modular components can be replaced quickly between runs, enabling scientists to test new media, feeds, or cell lines with minimal risk to the previous batch. This flexibility is particularly valuable in early‑ to mid‑phase development and in contract manufacturing environments where multiple clients and processes must be accommodated on the same facility footprint.
Reduced risk of cross‑contamination
Because the primary vessel is disposed of after each use, the risk of cross‑contamination between batches is substantially reduced. This is a major consideration for biologics, vaccines, and gene therapy products, where even trace carryover can compromise product quality or regulatory compliance. The sterile barrier of a SUB is reinforced by validated sterilisation of the bag material and connectors prior to shipment to the site.
Capital efficiency and lower upfront expenditure
Compared with stainless steel bioreactors, Single Use Bioreactor platforms often require lower upfront capital investment. The need for extensive CIP/SIP infrastructure, associated water utilities, and heavy-duty cleaning equipment is diminished. Over time, however, the consumable costs associated with disposable bags and ancillary components must be weighed in a total cost of ownership assessment. In many cases, the tCOE favours SUB for smaller to medium batch sizes or for processes with rapid iteration cycles.
Cleaner validation and faster commissioning
Validation activities for SUB platforms can be more straightforward when the disposable components have established sterility and integrity profiles. Commissioning can proceed with a modular approach: validate the control system and software, verify sensor accuracy, and test connectivity to upstream/downstream equipment in a staged manner. The result is faster regulatory alignment and a clearer path to manufacturing readiness.
Process consistency and standardisation
Disposable bags and standardized assemblies provide a degree of consistency that helps with process development and scale‑up. While traditional stainless steel systems rely heavily on operator technique for each calibration, SUB platforms can offer repeatable mixing patterns, gas transfer, and temperature control across campaigns, subject to proper procurement and lot–to–lot quality control of the consumables.
How Single Use Bioreactors work
Core components and their roles
A typical SINGLE USE Bioreactor comprises a disposable inner bag or chamber, a mechanical stirrer or agitation system, integrated or external sensors (pH, dissolved oxygen, temperature, OFF networks), and connections to gas lines and aseptic fluid paths. The exterior frame provides structural support and houses the drive system or motor that powers agitation. A control system interfaces with process sensors, actuates gas flow, and records data for real‑time monitoring and later analysis.
Gas transfer and mixing in a SUB
Proper gas transfer is essential for cell viability and productivity. SUBs often employ oxygen transfer via headspace gas and/or permeable polyolefin films in the bag material. Some designs use micro‑porous layers or membrane inserts to regulate oxygen delivery. Mixing is achieved through impellers or rotating bags in certain configurations. Controlling shear stress is critical to maintain cell health, particularly for shear‑sensitive mammalian cell cultures.
Sensor integration and process control
Sensor fidelity is central to successful bioprocess control. SUB platforms may rely on embedded sensors within the bag or external probes connected by sterile, single-use ports. Modern systems support inline data collection, digital automation, and remote monitoring. The degree of integration depends on the platform and the regulatory expectations for data integrity and traceability.
Sterility and containment considerations
Disposables are pre-sterilised and delivered in sealed packaging. Operators must maintain sterile technique when connecting bags and lines to the manufacturing suite. The containment strategy for viral or hazardous material processes remains governed by existing biosafety requirements and risk assessments. The design of the bag and connectors aims to minimise leak pathways and ensure robust containment during all stages of operation.
Materials and design considerations in a Single Use Bioreactor
Bag materials and barrier properties
Bag materials are typically multilayer polymer structures designed to balance mechanical strength, gas permeability, chemical resistance, and barrier properties. Common layers may include polyethylene, ethylene‑vinyl acetate, polyamide, and EVOH to provide oxygen barrier and chemical inertness. The selection of materials affects leachables and extractables, a critical area for regulatory compliance and product safety. Suppliers often provide lot‑specific data to support finishing and validation activities.
Seals, connections, and sterile interfaces
Seals and luer fittings, welding points, and sterile connectors are engineered to maintain integrity under transport, storage, and process conditions. The industry standard is to use ISO‑compliant connectors and validated aseptic interfaces. This reduces the risk of contamination and simplifies changeovers between campaigns with differing media or cell lines.
Sensor technology and calibration
Accurate monitoring requires robust sensors for pH, dissolved oxygen, temperature, and osmolality where relevant. Calibration protocols, drift checks, and routine verification are standard practice. Some platforms enable sensor redundancy or hybrid measurement strategies to improve data reliability and process stability without increasing the risk of contamination.
Mechanical aspects: agitation, cooling, and heat transfer
The design of the agitation mechanism, cooling channels, and insulation determines the thermal profile of the culture. Efficient heat transfer is vital for maintaining consistent growth environments and avoiding hotspots. SUBs may incorporate external cooling jackets or integrated coil systems to manage exothermic processes, depending on scale and product type.
Scalability: From Lab to Production
From research to manufacturing: planning the scale‑up path
Scalability is a principal driver for the adoption of Single Use Bioreactors. The modular nature of disposable components often enables seamless progression from small benchtop systems to pilot and production scales. A typical path could involve transitioning from a 2–3 litre benchtop SUB to 50–200 litre pilot systems and eventually integratin into 2000–5000 litre or larger production bioreactors, all using compatible disposable formats and process controls.
Process transfer and equivalence across scales
Achieving process equivalence across scales requires careful consideration of mixing times, oxygen transfer rates, nutrient delivery, and shear environment. Engineers employ scale‑down models, computational fluid dynamics (CFD), and pilot runs to ensure that performance in smaller SUBs accurately predicts larger systems. Consistency in consumables and connectors is essential to reduce variability during scale‑up.
Compatibility with downstream processing
Subsequent purification steps must be compatible with the output of the SUB platform. This includes considerations for feed streams, product stability, and compatibility with chromatography media. In some cases, integrated or modular single‑use downstream units simplify the overall process flow and reduce facility footprint.
Costs and Lifecycle: Total Cost of Ownership
Capital versus consumables: where the balance lies
The financial calculus for a Single Use Bioreactor involves upfront capital expenditure for the platform, plus ongoing costs for disposable bags, caps, sensors, and connection kits. A well‑executed cost model accounts for reduced cleaning utilities, lower water usage, and shorter downtime between campaigns. Depending on batch frequency, product value, and regulatory requirements, SUBs can deliver compelling total cost of ownership in both high‑throughput and regulated environments.
Waste management and sustainability costs
Disposables generate solid waste that must be handled in accordance with environmental and regulatory guidelines. The cost and environmental impact are often weighed against savings from reduced CIP/SIP cycles and diminished water consumption. Some organisations mitigate impact through recycling programs, supplier take‑back schemes, or by selecting materials designed for easier disposal or energy recovery.
Risk management and insurance implications
From a risk perspective, SUBs can simplify contamination control and validation, potentially reducing certain types of production risk. However, they introduce new risks related to supply chain reliability for consumables, lot‑to‑lot variability, and the need for robust vendor qualification. A proactive supplier management strategy and clear contingency plans help mitigate these concerns.
Operational Best Practices for Single Use Bioreactors
Supplier qualification and quality assurance
Qualified suppliers provide sterility testing, materials data, and delamination risk assessments. QA teams should verify that each batch of disposables comes with certificates of analysis, sterility validation, bioburden data, and integrity tests for critical components. Establishing clear supplier approval workflows reduces risk as campaigns change or scale.
Sterilisation, storage, and handling of disposables
Even though the primary vessel is disposable, proper handling of bags and connectors remains essential. Storage conditions, shelf life, and transport temperature must be controlled to preserve sterility and material integrity. Operators should follow established standard operating procedures (SOPs) for aseptic assembly and bag integration to ensure consistent results.
Process control strategy and data integrity
A robust control strategy uses validated sensors, reliable process analytics, and audit‑ready data capture. Data integrity practices, including secure data storage and traceability, are critical for regulatory compliance. The ability to trend and review performance across campaigns helps identify process drift and supports continuous improvement.
Maintenance and calibration of ancillary equipment
While the primary vessel is disposable, the ancillary systems—such as gas delivery, sampling probes, pumps, and control software—require routine maintenance and calibration. Establishing a maintenance calendar and vendor support agreements ensures uninterrupted production and reduces risk of unplanned downtime.
Regulatory and Quality Assurance Implications
GxP compliance and validation strategies
Single Use Bioreactors must operate within the same regulatory frameworks as traditional systems. This includes validation of the equipment, qualification of processes, and adherence to current good manufacturing practice (cGMP). Documentation should demonstrate that the disposable components meet predefined quality criteria and that process controls maintain product specifications throughout the lifecycle.
Change control and supplier management
Regulatory expectations require rigorous change control for any alterations in materials, suppliers, or processes. A formal change control process ensures that new disposables or updated components do not affect critical quality attributes. Supplier audits and ongoing performance reviews support a robust supply chain that aligns with compliance requirements.
Contamination control and sterility assurance
Contamination control is central to the regulatory narrative. SUBs benefit from simplified barrier management, but must still demonstrate effective sterility assurance. Validation studies for aseptic processing, environmental monitoring, and packaging integrity are essential, particularly for products with stringent safety profiles.
Environment and Sustainability of Disposable Systems
Environmental footprint considerations
Disposable systems can reduce water and energy usage but increase solid waste. A cradle‑to‑grave assessment helps organisations understand the trade‑offs. Where feasible, selecting recyclable or reusable components within a closed loop can mitigate environmental impact while preserving process integrity. Companies are increasingly reporting sustainability metrics to stakeholders and regulators, which influences procurement and process design decisions.
Industry best practices for sustainable disposal
Best practices include selecting materials with lower environmental impact, partnering with suppliers that offer take‑back or recycling programs, and optimising batch sizes to avoid unnecessary waste. In some regions, regulatory frameworks encourage manufacturers to document waste streams, treatment methods, and energy use reductions as part of corporate responsibility reporting.
Future Trends: The Next Generation of Single Use Bioreactors
Smart materials and advanced sensors
Advances in smart plastics, real‑time analytics, and micro‑sensor networks are expanding the capability of Single Use Bioreactors. Next‑generation disposables may feature integrated micro‑actuators, self‑monitoring seals, and smarter gas exchange control to optimise culture conditions without increasing operator workload.
Modular platforms and software‑defined processes
As platforms become more modular, software control and data analytics will increasingly define process performance. Operators may configure process templates in the cloud, enabling consistent deployment across sites while preserving local regulatory compliance. Version control for software and process parameters will become a standard element of SUB validation suites.
Hybrid models and recycling innovations
Hybrid approaches that combine disposable components with selective stainless steel interfaces may emerge to balance flexibility with durability. Innovations in recycling and waste valorisation could reduce environmental impact further, offering practical options for sustainable bioprocessing at scale.
Case Studies: Real World Adoption of Single Use Bioreactors
Biopharmaceutical development program accelerated by SUBs
A mid‑sized biopharma company implemented a Single Use Bioreactor strategy to fast‑track a plasmid‑based protein development program. By leveraging parallel runs with different media formulations, the team shortened development timelines by several months and delivered a robust data package to the regulatory team. The SUB approach enabled rapid iteration while maintaining strict sterility and data integrity standards.
Vaccine production with disposable systems
In a vaccine manufacturing scenario, the ability to rapidly reconfigure production lines for different strains while preserving a sterile environment proved invaluable. The downstream processing team found that standardised disposable components simplified changeovers and reduced overall facility downtime, supporting timely response to emerging health needs.
Contract manufacturing organization (CMO) scaling with SUB platforms
A CMO transitioning multiple clients to a single platform architecture used standardized SUBs to enable cross‑process compatibility. The platform supported tight batch traceability, regulatory documentation, and predictable performance across campaigns, improving client confidence and enabling the CMO to offer flexible manufacturing capacity with reduced lead times.
Conclusion: Choosing the Right Bioreactor for Your Process
The decision to adopt a Single Use Bioreactor should be guided by a holistic assessment of process requirements, regulatory obligations, financial implications, and the strategic goals of the organisation. For processes characterised by rapid development cycles, high variability in batch size, or the need for swift changeovers between campaigns, the SUB model offers compelling advantages. For more stable, large‑volume campaigns with well‑characterised materials and a trusted cleaning regime, a traditional stainless steel approach may still be appropriate, though a hybrid or staged adoption of disposable components can deliver benefits over time.
Key steps for selecting and deploying a Single Use Bioreactor include: defining the process requirements and scale targets, evaluating supplier quality and consumable support, validating sterility and process control, performing a total cost of ownership analysis, and implementing a lifecycle plan that considers waste, recycling, and regulatory documentation. With thoughtful planning and rigorous execution, the Single Use Bioreactor can become a cornerstone of efficient, compliant, and resilient bioprocessing.
Further considerations for organisations evaluating a Single Use Bioreactor
Organisation readiness and cultural fit
Successful adoption of disposable technologies requires alignment across manufacturing, quality, regulatory, and supply chain teams. Establishing cross‑functional steering committees, shared SOPs, and clear performance metrics supports a smooth transition and ongoing optimisation.
Supply chain resilience and contingency planning
Relying on single suppliers for critical disposables introduces potential vulnerability. Developing a diversified supplier base, maintaining safety stocks, and validating alternative components enable more robust operations in the face of disruptions or regulatory changes.
Training and workforce development
Operators and engineers require training on the unique handling, aseptic techniques, and changeover procedures associated with SUB platforms. Ongoing education, competency assessments, and refresher programmes help sustain performance and compliance across campaigns.
Glossary of key terms
- Single Use Bioreactor (SUB): A disposable, pre‑sterilised bioreactor platform with an integrated or modular setup for sterile processing.
- CIP/SIP: Cleaning In Place and Sterilisation In Place, methods traditionally used to maintain stainless steel bioreactor systems.
- Leachables and Extractables: Chemicals that may migrate from the disposable materials into the product, requiring qualification and monitoring.
- tCOE: Total Cost Of Ownership, a comprehensive financial metric used to compare capital and operating expenditures over the lifecycle.
In summary, the Single Use Bioreactor represents a pragmatic and forward‑looking pathway for modern bioprocessing—one that balances speed, flexibility, and robust process control with the regulatory rigour demanded by the industry. When implemented with careful planning, qualified suppliers, and a clear lifecycle strategy, the SUB platform can unlock faster development, more efficient manufacturing, and a more adaptable operation ready for the therapies of tomorrow.